Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Br J Dermatol ; 186(2): 341-351, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34477218

RESUMO

BACKGROUND: In children, psoriasis can be challenging to diagnose. Difficulties arise from differences in the clinical presentation compared with adults. OBJECTIVES: To test the diagnostic accuracy of previously agreed consensus criteria and to develop a shortlist of the best predictive diagnostic criteria for childhood psoriasis. METHODS: A case-control diagnostic accuracy study in 12 UK dermatology departments (2017-2019) assessed 18 clinical criteria using blinded trained investigators. Children (< 18 years) with dermatologist-diagnosed psoriasis (cases, N = 170) or a different scaly inflammatory rash (controls, N = 160) were recruited. The best predictive criteria were identified using backward logistic regression, and internal validation was conducted using bootstrapping. RESULTS: The sensitivity of the consensus-agreed criteria and consensus scoring algorithm was 84·6%, the specificity was 65·1% and the area under the curve (AUC) was 0·75. The seven diagnostic criteria that performed best were: (i) scale and erythema in the scalp involving the hairline, (ii) scaly erythema inside the external auditory meatus, (iii) persistent well-demarcated erythematous rash anywhere on the body, (iv) persistent erythema in the umbilicus, (v) scaly erythematous plaques on the extensor surfaces of the elbows and/or knees, (vi) well-demarcated erythematous rash in the napkin area involving the crural fold and (vii) family history of psoriasis. The sensitivity of the best predictive model was 76·8%, with specificity 72·7% and AUC 0·84. The c-statistic optimism-adjusted shrinkage factor was 0·012. CONCLUSIONS: This study provides examination- and history-based data on the clinical features of psoriasis in children and proposes seven diagnostic criteria with good discriminatory ability in secondary-care patients. External validation is now needed.


Assuntos
Psoríase , Adulto , Área Sob a Curva , Estudos de Casos e Controles , Criança , Humanos , Anamnese , Psoríase/diagnóstico , Reino Unido
4.
Clin Exp Dermatol ; 45(8): 1003-1010, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32246853

RESUMO

BACKGROUND: Chronic urticaria (CU) is a skin condition characterized by repeated occurrence of itchy weals and/or angio-oedema for > 6 weeks. AIM: To provide data demonstrating the real-life burden of CU in the UK. METHODS: This UK subset of the worldwide, prospective, noninterventional AWARE study included patients aged 18-75 years diagnosed with H1-antihistamine (H1-AH)-refractory chronic spontaneous urticaria (CSU) for > 2 months. Baseline characteristics, disease activity, treatments, comorbidities and healthcare resource use were documented. Quality of life (QoL), work productivity and activity impairment were assessed. RESULTS: Baseline analysis included 252 UK patients. Mean age and body mass index were 45.0 years and 29.0 kg/m2 , respectively. Most patients were female (77.8%) and had moderate/severe disease activity (mean Urticaria Activity Score over 7 days was 18.4) and a 'spontaneous' component to their CU (73.4% CSU; 24.6% CSU and chronic inducible urticaria). Common comorbidities included depression/anxiety (24.6%), asthma (23.8%) and allergic rhinitis (12.7%). A previous treatment was recorded for 57.9% of patients. Mean Dermatology Life Quality Index score was 9.5, and patients reported impairments in work productivity and activity. Healthcare resource use was high. Severity of CSU was associated with female sex, obesity, anxiety and diagnosis. Only 28.5% of patients completed all nine study visits, limiting analysis of long-term treatment patterns and disease impact. CONCLUSIONS: Adult H1-AH-refractory patients with CU in the UK reported high rates of healthcare resource use and impairment in QoL, work productivity and activity at baseline. The differing structures of UK healthcare may explain the high study discontinuation rates versus other countries.


Assuntos
Atividades Cotidianas/psicologia , Angioedema/patologia , Urticária Crônica/patologia , Recursos em Saúde/estatística & dados numéricos , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Adulto , Angioedema/etiologia , Antialérgicos/administração & dosagem , Antialérgicos/uso terapêutico , Índice de Massa Corporal , Urticária Crônica/diagnóstico , Urticária Crônica/tratamento farmacológico , Urticária Crônica/psicologia , Comorbidade , Efeitos Psicossociais da Doença , Ciclosporina/administração & dosagem , Ciclosporina/uso terapêutico , Eficiência , Feminino , Recursos em Saúde/provisão & distribuição , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/uso terapêutico , Masculino , Pessoa de Meia-Idade , Omalizumab/administração & dosagem , Omalizumab/uso terapêutico , Medidas de Resultados Relatados pelo Paciente , Estudos Prospectivos , Qualidade de Vida/psicologia , Índice de Gravidade de Doença , Reino Unido/epidemiologia
5.
Br J Dermatol ; 179(3): 582-589, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29774538

RESUMO

BACKGROUND: Infantile haemangiomas (IH) are the most common vascular tumours of infancy. Despite their frequency and potential complications, there are currently no unified U.K. guidelines for the treatment of IH with propranolol. There are still uncertainties and diverse opinions regarding indications, pretreatment investigations, its use in PHACES (posterior fossa malformations-haemangiomas-arterial anomalies-cardiac defects-eye abnormalities-sternal cleft and supraumbilical raphe) syndrome and cessation of treatment. OBJECTIVES: To provide unified guidelines for the treatment of IH with propranolol. METHODS: This study used a modified Delphi technique, which involved an international treatment survey, a systematic evidence review of the literature, a face-to-face multidisciplinary panel meeting and anonymous voting. RESULTS: The expert panel achieved consensus on 47 statements in eight categories, including indications and contraindications for starting propranolol, pretreatment investigations, starting and target dose, monitoring of adverse effects, the use of propranolol in PHACES syndrome and how to stop treatment. CONCLUSIONS: These consensus guidelines will help to standardize and simplify the treatment of IH with oral propranolol across the U.K. and assist in clinical decision-making.


Assuntos
Coartação Aórtica/tratamento farmacológico , Dermatologia/normas , Anormalidades do Olho/tratamento farmacológico , Hemangioma/tratamento farmacológico , Síndromes Neurocutâneas/tratamento farmacológico , Pediatria/normas , Propranolol/administração & dosagem , Neoplasias Cutâneas/tratamento farmacológico , Administração Oral , Tomada de Decisão Clínica , Consenso , Técnica Delphi , Humanos , Lactente , Sociedades Médicas/normas , Resultado do Tratamento , Reino Unido
6.
Clin Exp Dermatol ; 43(6): 713-717, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29744913

RESUMO

Cartilage-hair hypoplasia (CHH) is an autosomal recessive chondrodysplasia characterized by short-stature, sparse hair and impaired cellular immunity. We describe a young girl who was diagnosed with CHH based on the findings of recurrent infections, short stature with metaphyseal chondrodysplasia, and a confirmed bi-allelic RMRP gene mutation. At 13 years, the patient developed an Epstein-Barr virus (EBV)-driven lymphoproliferative disorder involving the lung, which responded partially to chemotherapy. Simultaneously, she developed multiple indurated plaques involving her face, which had histological findings of granulomatous inflammation and EBV-associated low-grade lymphomatoid granulomatosis. The patient received a matched unrelated peripheral blood stem cell transplant at 15 years of age, and her immunological parameters and skin lesions improved. Lymphomatoid forms of granulomatosis and cutaneous EBV-associated malignancies have not been described previously in CHH. This case highlights the possibility of EBV-associated cutaneous malignancy in CHH.


Assuntos
Cabelo/anormalidades , Doença de Hirschsprung/complicações , Síndromes de Imunodeficiência/complicações , Neoplasias Pulmonares/complicações , Pulmão/patologia , Granulomatose Linfomatoide/complicações , Osteocondrodisplasias/congênito , Neoplasias Cutâneas/complicações , Adolescente , Feminino , Herpesvirus Humano 4/isolamento & purificação , Doença de Hirschsprung/terapia , Humanos , Síndromes de Imunodeficiência/terapia , Pulmão/virologia , Neoplasias Pulmonares/patologia , Granulomatose Linfomatoide/patologia , Osteocondrodisplasias/complicações , Osteocondrodisplasias/terapia , Doenças da Imunodeficiência Primária , Transplante de Células-Tronco
8.
Clin Exp Dermatol ; 40(6): 605-10, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25809797

RESUMO

BACKGROUND: Elderly patients present with a unique spectrum of dermatoses that pose particular management opportunities and challenges, which will be increasingly encountered in dermatological practice. The skin of elderly patients differs from that of younger patients not only in appearance but also in structure, physiology and response to ultraviolet (UV) radiation. However, little is known about the safety and efficacy of phototherapy in elderly patients and how phototherapy is currently being utilized to treat them. AIM: To investigate the safety, efficacy and utilization of phototherapy in elderly patients. METHODS: In January 2014, we analysed all patients recently referred for, currently receiving or recently having completed a course of phototherapy at a university teaching hospital in England (UK). RESULTS: In total, 249 patients were identified; 37 (15%) were over the age of 65 years (the WHO definition of an elderly or older person). The dermatoses being treated were psoriasis (51%), eczema (11%), nodular prurigo (11%), pruritus (11%), Grover disease (5%) and others (11%). One patient with dementia was deemed not safe to embark on phototherapy, and five patients were yet to start. The remaining 31 elderly patients received 739 individual phototherapy treatments: 88% narrowband (NB)-UVB and 12% systemic, bath and hand/foot psoralen UVA (PUVA). The acute adverse event (AE) rate was 1.89%, all occurring in those receiving NB-UVB. No severe acute AEs occurred. Of those who completed their course of phototherapy, 80% achieved a clear/near clear or moderate response, while just two patients (8%) had minimal response and two (8%) had worsening of the disease during treatment. Of those receiving NB-UVB for psoriasis, 91% achieved a clear or near-clear response. CONCLUSIONS: In this small survey, the first of its kind to focus on elderly patients, phototherapy appears to be well-tolerated, safe and efficacious in the short term. Further thought and investigation should be given to delivering phototherapy to an ageing population.


Assuntos
Fotoquimioterapia/métodos , Dermatopatias/terapia , Terapia Ultravioleta/métodos , Idoso , Idoso de 80 Anos ou mais , Fármacos Dermatológicos/administração & dosagem , Eczema/tratamento farmacológico , Feminino , Ficusina/administração & dosagem , Humanos , Masculino , Fármacos Fotossensibilizantes/administração & dosagem , Raios Ultravioleta/efeitos adversos , Terapia Ultravioleta/efeitos adversos , Reino Unido
16.
Clin Exp Dermatol ; 32(6): 654-7, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17953634

RESUMO

Endemic zinc deficiency is recognised to be a common and serious problem in developing countries. However, it may be seen in routine practice in the UK, and can be easily overlooked. Malnutrition from any cause in conjunction with an undiagnosed cutaneous problem should alert the clinician to the diagnosis. Investigations may be unreliable, and if in doubt, a therapeutic trial of zinc supplementation is indicated. We present three cases of malnourished patients, in whom zinc deficiency was diagnosed after the development of cutaneous features. The malnutrition resulted from alcoholism in two cases and anorexia nervosa in the third. The heterogeneity of underlying causes of zinc deficiency is discussed, along with its effects, treatment and zinc homeostasis.


Assuntos
Exantema/etiologia , Desnutrição/complicações , Zinco/deficiência , Adulto , Idoso , Alcoolismo/complicações , Anorexia Nervosa/complicações , Exantema/tratamento farmacológico , Exantema/patologia , Feminino , Humanos , Masculino , Zinco/uso terapêutico
17.
J Obstet Gynaecol ; 26(5): 435-7, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16846871

RESUMO

A retrospective study of the referral patterns to a specialist vulval clinic was performed. A total of 200 clinical records were reviewed of new patients seen between January 2004 and June 2005. A provisional diagnosis was stated in 45.5% of referrals, of which 27.5% had the diagnosis changed at the clinic. The majority of referrals were from general practitioners (GPs) (77%) and smaller proportions from gynaecologists (11%), dermatologists (9%) and others (3%). The most common conditions seen were lichen sclerosus (39%), eczema/lichen simplex (30.5%), lichen planus (11.5%), pain syndromes (10.5%) and others (8.5%). Lichen sclerosus was accurately diagnosed in 54.5% of referrals but for eczema/lichen simplex it was only recognised in 11.5% of referrals. Nine cases of lichen sclerosus had been referred by gynaecologists after histological confirmation, for advice on management. Education of vulval diseases to non-specialists should focus on conditions that they are most likely to encounter and find difficult to manage. This study illustrates an effective method to define what the local teaching requirements are.


Assuntos
Medicina , Especialização , Doenças da Vulva/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Instituições de Assistência Ambulatorial , Criança , Pré-Escolar , Feminino , Humanos , Pessoa de Meia-Idade , Encaminhamento e Consulta , Doenças da Vulva/terapia
20.
J Eur Acad Dermatol Venereol ; 20(2): 212-3, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16441636

RESUMO

We report three paediatric cases of severe allergic contact dermatitis caused by a Japanese lacquer tree (Rhus verniciflua), which is a rare specimen plant in the UK. The diagnosis of allergic contact dermatitis produced by plants that are not indigenous to a particular country is more likely to be delayed, as well as mistaken for cellulitis.


Assuntos
Alérgenos/efeitos adversos , Dermatite por Toxicodendron/diagnóstico , Resinas Vegetais/efeitos adversos , Rhus/efeitos adversos , Pré-Escolar , Dermatite por Toxicodendron/patologia , Diagnóstico Diferencial , Humanos , Perna (Membro)/patologia , Masculino , Testes do Emplastro , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...